These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30033133)

  • 41. Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation.
    Khan IA
    Int J Cardiol; 2003 Feb; 87(2-3):121-8. PubMed ID: 12559528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable atrial defibrillator and detection of atrial flutter.
    Schwartz M; Maglio C; Akhtar M; Sra J
    J Interv Card Electrophysiol; 2000 Apr; 4(1):257-9. PubMed ID: 10729843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS; Wood MA; Ellenbogen KA
    Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.
    Van Gelder IC; Crijns HJ; Van Gilst WH; Van Wijk LM; Hamer HP; Lie KI
    Am J Cardiol; 1989 Dec; 64(19):1317-21. PubMed ID: 2511744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of atrial paralysis during the use of intravenous flecainide acetate].
    Tognarini S; Pardini E
    Cardiologia; 1989 Aug; 34(8):725-9. PubMed ID: 2514041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias.
    Brembilla-Perrot B; Houriez P; Beurrier D; Claudon O; Terrier de la Chaise A; Louis P
    Int J Cardiol; 2001 Aug; 80(1):7-15. PubMed ID: 11532541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ranolazine terminates atrial flutter and fibrillation in a canine model.
    Bhimani AA; Yasuda T; Sadrpour SA; Khrestian CM; Lee S; Zeng D; Belardinelli L; Waldo AL
    Heart Rhythm; 2014 Sep; 11(9):1592-9. PubMed ID: 25066042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of flecainide on termination of atrial flutter by rapid atrial pacing.
    Heldal M; Orning OM
    Eur Heart J; 1993 Mar; 14(3):421-4. PubMed ID: 8458365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].
    Carbucicchio C; Lavarra F; Riva S; Fassini G; Della Bella P
    Cardiologia; 1995 Dec; 40(12):927-40. PubMed ID: 8901043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
    Bertaglia E; Bonso A; Zoppo F; Proclemer A; Verlato R; Corò L; Mantovan R; Themistoclakis S; Raviele A; Pascotto P;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1507-12. PubMed ID: 15546305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
    Hohnloser SH; Zabel M
    Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm.
    Botto GL; Bonini W; Broffoni T; Cappelletti G; Falcone C; Lombardi R; Paulesu A; Pedraglio E; Ferrari G
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2114-7. PubMed ID: 7845827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation.
    Nabar A; Rodriguez LM; Timmermans C; van den Dool A; Smeets JL; Wellens HJ
    Circulation; 1999 Mar; 99(11):1441-5. PubMed ID: 10086967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Lie-A-Huen L; Mast EG
    Am J Cardiol; 1989 Mar; 63(11):693-6. PubMed ID: 2493733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flecainide in quinidine-resistant atrial fibrillation.
    Leclercq JF; Chouty F; Denjoy I; Coumel P; Slama R
    Am J Cardiol; 1992 Aug; 70(5):62A-65A. PubMed ID: 1510001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal intractable atrial flutter successfully treated with intravenous flecainide.
    Suzumura H; Nitta A; Ono M; Arisaka O
    Pediatr Cardiol; 2004; 25(2):154-6. PubMed ID: 14681740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
    Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
    Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.